Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 909-044-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Comparable to guideline study with restrictions (No information about environmental conditions and housing, only male mice were tested, misssing reproducibility). Adopted according to OECD SIDS (public available peer reviewed source). The original source is available and has been reviewed.
Data source
Referenceopen allclose all
- Reference Type:
- publication
- Title:
- Evaluation o a three-exposure mouse bone marrow micronucleus protocol: results with 49 chemicals
- Author:
- Shelby MD, Erexson GL, Hook GJ, Tice RR
- Year:
- 1 993
- Bibliographic source:
- Environ Mol Mutagen 21: 160 - 179
- Reference Type:
- publication
- Title:
- Comparative activity of human|carcinogens and NTP rodent carcinogens in the mouse bone marrow micronucleus assay: An integrative approach to genetic toxicity data assessment
- Author:
- Tinwell H, Ashby J
- Year:
- 1 994
- Bibliographic source:
- Environ Health Perspect 102: 758 - 762
- Reference Type:
- secondary source
- Title:
- Dimethyl phosphonate - CAS No: 868-85-9 - SIDS Initial Assessment Report.
- Author:
- OECD
- Year:
- 2 006
- Bibliographic source:
- UNEP Publications
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- No information about environmental conditions and housing, only male mice were tested, missing reproducibility
- GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Dimethyl phosphonate
- EC Number:
- 212-783-8
- EC Name:
- Dimethyl phosphonate
- Cas Number:
- 868-85-9
- Molecular formula:
- C2H7O3P
- IUPAC Name:
- dimethyl phosphonate
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): dimethyl hydrogen phosphite.
- Analytical purity: 97.8 %
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: the animals were obtained from the National Toxicology Program production facility at Taconic Farms, USA.
- Age at study initiation: between 9 and 14 weeks old.
- Weight at study initiation: within a 2 g range of a mean weight between 25 and 33 g.
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: PBS
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test chemical was prepared in the appropriate solvent and mixed using a S/P vortex Mixer. The test chemical was administered within 30 minutes of preparation. - Duration of treatment / exposure:
- The animals were sacrified 24 hour after last injection.
- Frequency of treatment:
- Three consecutive days (one injection/day).
- Post exposure period:
- 24 hours after the last exposure
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 250, 500 mg/kg bw/d
Basis:
nominal conc.
- No. of animals per sex per dose:
- 5 (only male mice were tested)
- Control animals:
- other: negative control animals (concurrent vehicle); positive control animals.
- Positive control(s):
- 7,12-dimethylbenzanthracene (DMBA); mitomycin C (MMC)
- Route of administration: intraperitoneal injection
- Doses / concentrations: 7,12-dimethylbenzanthracene - DMBA (12.5 mg/kg), mitomycin C - MMC (0.2 mg/kg)
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The selection of the maximum dose to be tested for micronucleus induction was based on either mortality, administration characteristics (ability to be administered as a homogeneous suspension in corn oil or dissolved in PBS), depression in the percentage of bone marrow PCE (no less than 15% of the erythrocytes), or on the arbitrary maximum dose of 2000 mg/kg/day.
Generally, unless LD50 data were available to suggest an appropriate dose range to test, the initial doses tested were 200, 1000, and 2000 mg/kg.
Groups of 5 mice were administered the test chemical by i.p. injection on the three consecutive days. Animals were monitored twice daily, and 48 hours after the third treatment, the surviving mice were euthanized by CO2 asphyxiation. Bone marrow smears (two/slides/tissue/mouse) were prepared by a direct technique.
Air-dried smears were fixed using absolute methanol and stained with acridine orange. Bone marrow from each animal were evaluated at 1000x magnification using epi-illuminated fluorescence microscopy (450-490 nm excitation, 520 nm emission) for determination of the percentage of PCE among 200 erythrocytes. Based on the results obtained, the maximum administered dose was estimated or additional dose determination experiments were conducted to more accurately estimate the maximum dose to be tested in the primary micronucleus test.
TREATMENT AND SAMPLING TIMES
For the initial micronucleus test, groups of 5 animals were injected i.p. on the three consecutive days with either the test chemical, a weakly active dose of the positive control chemical (DMBA in corn oil, MMC in PBS), or the appropriate solvent. Mice were euthanized with CO2 24 hours after the thirds treatment.
DETAILS OF SLIDE PREPARATION
Bone marrow smears (two slides mouse) were prepared, fixed in absolute methanol, and stained with acridine orange. For each animal, slides were evaluated at 1000x magnification for number for the number of MN-PCE among 2000 PCE and for the percentage of PCE among 200 erythrocytes.
- Statistics:
- The data were analyzed using the Micronucleus Assay Data Management and Statistical software package (version 1.4), which was designed specifically for in vivo micronucleus data [ILS, 1990. Integrated Laboratory Systems. P.O Box 13501, Research Triangle Park, NC 27709]. The level of significance was set at an alpha level of 0.05. To determine whether a specific treatment resulted in a significant increase in MN-PCE, the number of MN-PCE were pooled within each dose group and analyzed by one-tailed trend test. In the software package used, the trend test incorporates a variance inflation factor to account for excess animal variability. In the event that the increase in the dose response curve is nonmonotonic, the software program allows for the data to be analyzed for a significant positive trend after data at the highest dose only has been excluded. However, in this event, the alpha level is adjusted to 0.01 to protect against false positive. The % PCE data were analyzed by an analysis of variance (ANOVA) test based on pooled data. Pairwise comparisons between each groups and the concurrent solvent control group was by an unadjusted one-tailed Pearson chi-squared test which incorporated the calculated variance inflation factor for the study.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- positive
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- The initial test gave a positive trend from 2.1 in the control to 6.1 at 500 mg/kg (trend P-value <0.001); the trend analysis of the repeat test gave p= 0.078 with the MNC-PCE frequency ranging from a control of 2.7 to 4.2 in high dose. Although not showing a reproducible, statistically significant increase in MN-PCE, the data were judged to be adequate evidence of an effect.
Any other information on results incl. tables
Table1. Micronucleus Data
Chemical |
Tissue |
Trend P-value |
Dose (mg/kg) | MN-PCE/1000 (No. animals) |
Pair-wise |
Survivals |
% PCE |
First trial | |||||||
Dimethyl hydrogen phosphite | bone marrow | < 0.001 |
0 | 2.10 ± 0.64 (5) | 5/5 | 29.5 |
|
250 | 1.10 ± 0.37 (5) | 0.9616 | 5/5 | 42.8 |
|||
500 | 6.10 ± 0.94 (5) | <0.001 | 5/5 | 30.6 |
|||
Second trial | |||||||
Dimethyl hydrogen phosphite | bone marrow | 0.078 |
0 | 2.70 ± 0.56 (5) | 5/5 | 50.3 | |
250 | 2.20 ± 0.26 (5) | 0.7627 | 5/5 | 41.7 | |||
500 | 4.17 ± 0.44 (5) | 0.0573 | 3/5 | 19.7 |
Positive Control DMBA / mean mn PCE: 6.93 +/- 2.59
Positive Control MMC / mean mn PCE: 6.82 +/- 1.24
*: statistically significant
PCE - polychromatic erythrocytes
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
positive - Executive summary:
Shelby (1993)
Dimethyl phosphonate was tested in a mouse bone marrow micronucleus test that employed three daily exposures by intraperitoneal injection (i.p.). Bone marrow samples were obtained 24 hours following the final exposure.
For the initial micronucleus test, groups of 5 animals were injected i.p.during three consecutive days with either the test chemical (0, 250, 500 mg/kg bw), a weakly active dose of the positive control chemical (DMBA in corn oil, MMC in PBS), or the appropriate solvent. Mice were euthanized with CO2 24 hours after the third treatment.
The initial test gave a positive trend from 2.1 in the control to 6.1 at 500 mg/kg (trend P-value < 0.001); the trend analysis of the repeat test gave p= 0.078 with the MNC-PCE frequency ranging from a control of 2.7 to 4.2 in high dose. Although not showing a reproducible, statistically significant increase in MN-PCE, the data were judged to be adequate evidence of an effect.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.